Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ajay Vora

Showing results (31-40 of 166) with videos related to

Pageof 17
Sort By:
British Journal of Clinical Pharmacology|December 21, 2012
Thiopurine methyltransferase genotype-phenotype discordance and thiopurine active metabolite formation in childhood acute lymphoblastic leukaemiaLynne Lennard, Cher Suzanne Cartwright, Rachel Wade, et al.
Blood|September 3, 2011
Polymorphism in the PAI-1 (SERPINE1) gene and the risk of osteonecrosis in children with acute lymphoblastic leukemiaJonathan Bond, Stuart Adams, Susan Richards, et al.
The Lancet. Haematology|October 29, 2021
Defining low-risk high hyperdiploidy in patients with paediatric acute lymphoblastic leukaemia: a retrospective analysis of data from the UKALL97/99 and UKALL2003 clinical trialsAmir Enshaei, Ajay Vora, Christine J Harrison, et al.
British Journal of Haematology|June 25, 2009
The impact of risk stratification by early bone-marrow response in childhood lymphoblastic leukaemia: results from the United Kingdom Medical Research Council trial ALL97 and ALL97/99Christopher Mitchell, Jeanette Payne, Rachel Wade, et al.
British Journal of Haematology|December 20, 2015
Efficacy and toxicity of a paediatric protocol in teenagers and young adults with Philadelphia chromosome negative acute lymphoblastic leukaemia: results from UKALL 2003Rachael Hough, Clare Rowntree, Nick Goulden, et al.
Clinical Pharmacology and Therapeutics|October 4, 2006
The thiopurine methyltransferase genetic polymorphism is associated with thioguanine-related veno-occlusive disease of the liver in children with acute lymphoblastic leukemiaLynne Lennard, Sue Richards, Cher S Cartwright, et al.
Blood Advances|April 21, 2021
Activity of blinatumomab in lymphoblastic leukemia with impaired T-cell immunity due to congenital immunodeficiencySandheeah Ramdeny, Asima Chaudhary, Austen Worth, et al.
British Journal of Haematology|February 3, 2005
GATA1 mutation and trisomy 21 are required only in haematopoietic cells for development of transient myeloproliferative disorderEmily Carpenter, Veronica Valverde-Garduno, Alex Sternberg, et al.
The Lancet. Oncology|February 12, 2013
Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trialAjay Vora, Nick Goulden, Rachel Wade, et al.
British Journal of Haematology|June 12, 2013
Incidence and outcome of pancreatitis in children and young adults with acute lymphoblastic leukaemia treated on a contemporary protocol, UKALL 2003Sujith Samarasinghe, Sunita Dhir, James Slack, et al.
Pageof 17

Showing results (31-40 of 166) with videos related to

Sort By:
Pageof 17
British Journal of Clinical Pharmacology|December 21, 2012
Thiopurine methyltransferase genotype-phenotype discordance and thiopurine active metabolite formation in childhood acute lymphoblastic leukaemiaLynne Lennard, Cher Suzanne Cartwright, Rachel Wade, et al.
Blood|September 3, 2011
Polymorphism in the PAI-1 (SERPINE1) gene and the risk of osteonecrosis in children with acute lymphoblastic leukemiaJonathan Bond, Stuart Adams, Susan Richards, et al.
The Lancet. Haematology|October 29, 2021
Defining low-risk high hyperdiploidy in patients with paediatric acute lymphoblastic leukaemia: a retrospective analysis of data from the UKALL97/99 and UKALL2003 clinical trialsAmir Enshaei, Ajay Vora, Christine J Harrison, et al.
British Journal of Haematology|June 25, 2009
The impact of risk stratification by early bone-marrow response in childhood lymphoblastic leukaemia: results from the United Kingdom Medical Research Council trial ALL97 and ALL97/99Christopher Mitchell, Jeanette Payne, Rachel Wade, et al.
British Journal of Haematology|December 20, 2015
Efficacy and toxicity of a paediatric protocol in teenagers and young adults with Philadelphia chromosome negative acute lymphoblastic leukaemia: results from UKALL 2003Rachael Hough, Clare Rowntree, Nick Goulden, et al.
Clinical Pharmacology and Therapeutics|October 4, 2006
The thiopurine methyltransferase genetic polymorphism is associated with thioguanine-related veno-occlusive disease of the liver in children with acute lymphoblastic leukemiaLynne Lennard, Sue Richards, Cher S Cartwright, et al.
Blood Advances|April 21, 2021
Activity of blinatumomab in lymphoblastic leukemia with impaired T-cell immunity due to congenital immunodeficiencySandheeah Ramdeny, Asima Chaudhary, Austen Worth, et al.
British Journal of Haematology|February 3, 2005
GATA1 mutation and trisomy 21 are required only in haematopoietic cells for development of transient myeloproliferative disorderEmily Carpenter, Veronica Valverde-Garduno, Alex Sternberg, et al.
The Lancet. Oncology|February 12, 2013
Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trialAjay Vora, Nick Goulden, Rachel Wade, et al.
British Journal of Haematology|June 12, 2013
Incidence and outcome of pancreatitis in children and young adults with acute lymphoblastic leukaemia treated on a contemporary protocol, UKALL 2003Sujith Samarasinghe, Sunita Dhir, James Slack, et al.
Pageof 17